https://www.selleckchem.com/products/odm208.html
The design principle and category of smart PROTACs are introduced along with an overview of their therapeutic prospects and challenges. Multiparametric magnetic resonance imaging (mpMRI) has improved the early detection of clinically significant prostate cancer (csPCa). However, an appropriate selection of men for mpMRI or prostate biopsy is still challenging, which is why new biomarkers or predictive models are recommended to determine those patients who will benefit from prostate biopsy. Proclarix is a new test that provides the risk o
Like
Comment
Share
